Moderna Inc. is the second pharmaceutical in a week to announce that an independent monitoring board has found its vaccine highly effective against COVID-19. Moderna’s Phase 3 showed 94.5% efficacy. Last Monday, Pfizer’s Phase 3 vaccine showed a 90% success rate in fighting the virus. The FDA has said it would accept vaccines that showed greater than 50% efficacy.